01—Abstract
Summary
Summary of the 10-Q filed August 7, 2024. Cited figures are marked; the original filing is the authoritative source.
CVS Health Corporation reported revenues of $91.23 billiona for the second quarter of 2024, a 2.6% increase year-over-year, primarily driven by growth in its Health Care Benefits and Pharmacy & Consumer Wellness segments.
However, net income attributable to CVS Health decreased by 6.9% to $1.77 billionb, or $1.41 per diluted share. This decline was largely influenced by increased health care costs, particularly within the Health Care Benefits segment, where the Medical Benefit Ratio (MBR) rose to 89.6% due to higher utilization and the impact of reduced Medicare Advantage star ratings. The Health Services segment experienced an 8.8% revenue decrease due to client losses and pricing pressures, though adjusted operating income saw a slight increase.
The company continued its strategic investments, including the integration of Oak Street Health and Signify Health, and actively managed its capital through share repurchases and debt issuance. Looking ahead, CVS Health anticipates continued elevated utilization in Medicare Advantage programs, which is expected to pressure its Health Care Benefits segment and health care delivery assets. The company also faces medical cost pressures in its Medicaid business due to higher acuity following member redeterminations.
Despite these challenges, CVS Health expects growth in its newer ventures like Cordavis, Oak Street Health, and Signify Health, and is focused on enterprise-wide cost savings initiatives to improve its operating cost structure. The company maintains a strong liquidity position with $12.5 billionc in cash and cash equivalents as of June 30, 2024.
02—Key points
Key Highlights
- Total revenues for Q2 2024 increased by 2.6% to $91.23 billion, primarily driven by the Health Care Benefits and Pharmacy & Consumer Wellness segments.
- Net income attributable to CVS Health decreased by 6.9% to $1.77 billion ($1.41 per diluted share) due to increased health care costs and the impact of Medicare utilization.
- The Medical Benefit Ratio (MBR) in the Health Care Benefits segment increased to 89.6% from 86.2% year-over-year, driven by higher utilization and a negative impact from Medicare Advantage star ratings.
- Health Services segment revenues declined by 8.8% to $42.17 billion, impacted by client losses and pricing pressures, although adjusted operating income saw a slight 1.1% increase.
- Pharmacy & Consumer Wellness segment revenues grew by 3.7% to $29.84 billion, supported by increased prescription volume, but adjusted operating income decreased by 12.0% due to reimbursement pressures.
- CVS Health repurchased $3.0 billion of its common stock during the first six months of 2024, demonstrating a commitment to returning capital to shareholders.
- The company ended the quarter with a strong cash position of $12.5 billion, providing flexibility for operations and strategic initiatives.
03—One dollar
Follow one dollar
Of each $1.00 of revenue in Q2 FY2024, CVS Health Corp kept $0.02.
- Revenue$91.23B100.0%
- Cost of revenue−$50.00B54.8%
- Gross profit$41.24B45.2%
- Operating costs−$38.19B41.9%
- Operating income$3.04B3.3%
- Interest, other & tax−$1.28B1.4%
- Net income$1.77B1.9%
04—Financials
Financial Highlights
Figures from 10-QQ2 FY2024filed August 7, 2024Financial Statements
Q2 FY2024 against Q2 FY2023
| Line item | Q2 FY2024Q2 FY2023 | Change |
|---|---|---|
| Revenue | $91.23B$88.92B | +2.6% |
| Cost of Revenue | $50.00B$53.54B | −6.6% |
| Gross Profit | $41.24B$35.38B | +16.5% |
| Operating Expenses | $88.19B$85.69B | +2.9% |
| Operating Income | $3.04B$3.23B | −5.8% |
| Net Income | $1.77B$1.91B | −7.6% |
| EPS (Basic) | $1.41$1.48 | −4.7% |
| EPS (Diluted) | $1.41$1.48 | −4.7% |
| Shares Outstanding (Basic) | 1.26B1.28B | −2.1% |
| Shares Outstanding (Diluted) | 1.26B1.29B | −2.2% |
05—Questions
Frequently Asked Questions
What were the primary drivers of CVS Health's revenue growth in the second quarter?
Total revenues increased by 2.6% to $91.23 billion, primarily driven by growth in the Health Care Benefits segment (up 21.4% in total revenues) and the Pharmacy & Consumer Wellness segment (up 3.7% in total revenues). This growth was partially offset by a decline in the Health Services segment.
What is the impact of increased health care costs on CVS Health's profitability?
Increased health care costs, particularly within the Health Care Benefits segment, significantly impacted profitability. The Medical Benefit Ratio (MBR) rose to 89.6% due to higher utilization and the effect of reduced Medicare Advantage star ratings. This, along with other cost pressures, led to a 6.9% decrease in net income attributable to CVS Health.
How is the company managing its capital and shareholder returns?
CVS Health maintained a strong liquidity position with $12.5 billion in cash and cash equivalents as of June 30, 2024. The company also repurchased approximately $3.0 billion of its common stock during the first six months of 2024, demonstrating a continued focus on returning capital to shareholders.
What are the key headwinds the company anticipates for the remainder of the year?
The company expects continued elevated utilization in Medicare Advantage programs, which will likely pressure its Health Care Benefits segment and health care delivery assets. Additionally, its Medicaid business is facing medical cost pressures due to higher acuity following member redeterminations. Supply disruptions for GLP-1 medications could also impact results.
06—Continue